Dr. Casares is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7889 Gateway East Blvd
2nd floor
El Paso, TX 79915Phone+1 915-300-3484Fax+1 915-300-3484
Summary
- Board certified in Internal Medicine and Nephrology
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Geriatric Medicine (Internal Medicine), 2013 - 2014
- Icahn School of Medicine at Mount Sinai (Morningside/West)Fellowship, Nephrology, 2011 - 2013
- Icahn School of Medicine at Mount Sinai/Morningside/WestChief Residency, Internal Medicine, 2010 - 2011
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2007 - 2010
- Universidad Catolica ArgentinaGI surgeon, GI Surgery , 2006 - 2007
- Universidad de Buenos Aires (UBA)General Surgeon, General Surgery, 2002 - 2006
- Maimonides University Faculty of MedicineClass of 2001
- Manhattan InstituteDialysis technician
Certifications & Licensure
- TX State Medical License 2013 - 2025
- NM State Medical License 2016 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 6 citationsDiffuse alveolar haemorrhage in ANCA-negative pauci-immune crescentic glomerulonephritisGagangeet Sandhu, Pablo Casares, Antony A. Farias, Aditi Ranade, J. Jones
NDT Plus. 2010-10-01 - 10 citationsNosocomial valve endocarditis due to corynebacterium striatum: a case report.Jorge Marull, Pablo A Casares
Cases Journal. 2008-12-12 - 10 citationsOver a millon Creatine Kinase due to a heavy work-out: A case report.Pablo A Casares, Jorge Marull
Cases Journal. 2008-09-20
Press Mentions
- Borderland Workshop Aims to Help Those Who Care for the ElderlyOctober 31st, 2019
Research History
- Sub investigatorA study to evaluate the effect of dapagliflozin on renal outcomes and cardiovascular disease in patients with chronic kidney disease Study D169AC00001 Sponsor Astra Zeneca AB2017 - Present
- Sub investigatorPhase 3 , randomized placebo controlled , prospective, multicenter study with oral ferric mástil for the treatment of iron deficiency anemia in subjects with ckd Protocol n: ST10-01-303 Sponsor : Shield TX (U.K. ) limited2017 - Present
Professional Memberships
- Member
- Member
- American society for ApheresisMember
Other Languages
- Spanish
External Links
- Ncqa accretidation PCMHhttp://Reportcards.ncqa.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: